Hospital acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries.
麻豆原创 Analysis and Insights: Global Hospital Infection Prevention And Control 麻豆原创
The global Hospital Infection Prevention And Control market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Hospital Infection Prevention And Control market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hospital Infection Prevention And Control, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hospital Infection Prevention And Control, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hospital Infection Prevention And Control revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hospital Infection Prevention And Control market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hospital Infection Prevention And Control revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
3M Company
Ansell Ltd.
Belimed AG
Bemis Company, Inc.
B. Braun Melsungen AG
Cantel Medical Corp.
Cardinal Health, Inc.
Covidien plc.
Crosstex International, Inc.
Danaher Corp.
Diversey, Inc.
Getinge Group
Johnson & Johnson
Halyard Health, Inc.
Matachana Group
Medivators, Inc.
Purdue Pharma LP
Sealed Air Corp.
Semperit AG Holding
Synergy Health plc.
Terumo Corp.
Segment by Type
Infection Prevention Supplies
Infection Prevention Equipment
Infection Prevention Services
Segment by Application
Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
MRSA
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hospital Infection Prevention And Control in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Infection Prevention And Control companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hospital Infection Prevention And Control revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Hospital Infection Prevention And Control 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Infection Prevention Supplies
1.2.3 Infection Prevention Equipment
1.2.4 Infection Prevention Services
1.3 麻豆原创 by Application
1.3.1 Global Hospital Infection Prevention And Control 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pneumonia
1.3.3 Urinary Tract Infection
1.3.4 Blood Stream Infection
1.3.5 Surgical Site Infection
1.3.6 MRSA
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Infection Prevention And Control 麻豆原创 Perspective (2019-2030)
2.2 Global Hospital Infection Prevention And Control Growth Trends by Region
2.2.1 Hospital Infection Prevention And Control 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital Infection Prevention And Control Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Hospital Infection Prevention And Control Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Hospital Infection Prevention And Control 麻豆原创 Dynamics
2.3.1 Hospital Infection Prevention And Control Industry Trends
2.3.2 Hospital Infection Prevention And Control 麻豆原创 Drivers
2.3.3 Hospital Infection Prevention And Control 麻豆原创 Challenges
2.3.4 Hospital Infection Prevention And Control 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hospital Infection Prevention And Control by Players
3.1.1 Global Hospital Infection Prevention And Control Revenue by Players (2019-2024)
3.1.2 Global Hospital Infection Prevention And Control Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Hospital Infection Prevention And Control 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hospital Infection Prevention And Control, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Hospital Infection Prevention And Control 麻豆原创 Concentration Ratio
3.4.1 Global Hospital Infection Prevention And Control 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Infection Prevention And Control Revenue in 2023
3.5 Global Key Players of Hospital Infection Prevention And Control Head office and Area Served
3.6 Global Key Players of Hospital Infection Prevention And Control, Product and Application
3.7 Global Key Players of Hospital Infection Prevention And Control, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Infection Prevention And Control Breakdown Data by Type
4.1 Global Hospital Infection Prevention And Control Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Hospital Infection Prevention And Control Forecasted 麻豆原创 Size by Type (2025-2030)
5 Hospital Infection Prevention And Control Breakdown Data by Application
5.1 Global Hospital Infection Prevention And Control Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Hospital Infection Prevention And Control Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Hospital Infection Prevention And Control 麻豆原创 Size (2019-2030)
6.2 North America Hospital Infection Prevention And Control 麻豆原创 Size by Type
6.2.1 North America Hospital Infection Prevention And Control 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Hospital Infection Prevention And Control 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Hospital Infection Prevention And Control 麻豆原创 Share by Type (2019-2030)
6.3 North America Hospital Infection Prevention And Control 麻豆原创 Size by Application
6.3.1 North America Hospital Infection Prevention And Control 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Hospital Infection Prevention And Control 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Hospital Infection Prevention And Control 麻豆原创 Share by Application (2019-2030)
6.4 North America Hospital Infection Prevention And Control 麻豆原创 Size by Country
6.4.1 North America Hospital Infection Prevention And Control 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hospital Infection Prevention And Control 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Hospital Infection Prevention And Control 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hospital Infection Prevention And Control 麻豆原创 Size (2019-2030)
7.2 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Type
7.2.1 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Hospital Infection Prevention And Control 麻豆原创 Share by Type (2019-2030)
7.3 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Application
7.3.1 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Hospital Infection Prevention And Control 麻豆原创 Share by Application (2019-2030)
7.4 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Country
7.4.1 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Hospital Infection Prevention And Control 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hospital Infection Prevention And Control 麻豆原创 Size (2019-2030)
8.2 China Hospital Infection Prevention And Control 麻豆原创 Size by Type
8.2.1 China Hospital Infection Prevention And Control 麻豆原创 Size by Type (2019-2024)
8.2.2 China Hospital Infection Prevention And Control 麻豆原创 Size by Type (2025-2030)
8.2.3 China Hospital Infection Prevention And Control 麻豆原创 Share by Type (2019-2030)
8.3 China Hospital Infection Prevention And Control 麻豆原创 Size by Application
8.3.1 China Hospital Infection Prevention And Control 麻豆原创 Size by Application (2019-2024)
8.3.2 China Hospital Infection Prevention And Control 麻豆原创 Size by Application (2025-2030)
8.3.3 China Hospital Infection Prevention And Control 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Hospital Infection Prevention And Control 麻豆原创 Size (2019-2030)
9.2 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Type
9.2.1 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Hospital Infection Prevention And Control 麻豆原创 Share by Type (2019-2030)
9.3 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Application
9.3.1 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Hospital Infection Prevention And Control 麻豆原创 Share by Application (2019-2030)
9.4 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Region
9.4.1 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Hospital Infection Prevention And Control 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Hospital Infection Prevention And Control 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 3M Company
11.1.1 3M Company Company Details
11.1.2 3M Company Business Overview
11.1.3 3M Company Hospital Infection Prevention And Control Introduction
11.1.4 3M Company Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.1.5 3M Company Recent Developments
11.2 Ansell Ltd.
11.2.1 Ansell Ltd. Company Details
11.2.2 Ansell Ltd. Business Overview
11.2.3 Ansell Ltd. Hospital Infection Prevention And Control Introduction
11.2.4 Ansell Ltd. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.2.5 Ansell Ltd. Recent Developments
11.3 Belimed AG
11.3.1 Belimed AG Company Details
11.3.2 Belimed AG Business Overview
11.3.3 Belimed AG Hospital Infection Prevention And Control Introduction
11.3.4 Belimed AG Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.3.5 Belimed AG Recent Developments
11.4 Bemis Company, Inc.
11.4.1 Bemis Company, Inc. Company Details
11.4.2 Bemis Company, Inc. Business Overview
11.4.3 Bemis Company, Inc. Hospital Infection Prevention And Control Introduction
11.4.4 Bemis Company, Inc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.4.5 Bemis Company, Inc. Recent Developments
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Company Details
11.5.2 B. Braun Melsungen AG Business Overview
11.5.3 B. Braun Melsungen AG Hospital Infection Prevention And Control Introduction
11.5.4 B. Braun Melsungen AG Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.5.5 B. Braun Melsungen AG Recent Developments
11.6 Cantel Medical Corp.
11.6.1 Cantel Medical Corp. Company Details
11.6.2 Cantel Medical Corp. Business Overview
11.6.3 Cantel Medical Corp. Hospital Infection Prevention And Control Introduction
11.6.4 Cantel Medical Corp. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.6.5 Cantel Medical Corp. Recent Developments
11.7 Cardinal Health, Inc.
11.7.1 Cardinal Health, Inc. Company Details
11.7.2 Cardinal Health, Inc. Business Overview
11.7.3 Cardinal Health, Inc. Hospital Infection Prevention And Control Introduction
11.7.4 Cardinal Health, Inc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.7.5 Cardinal Health, Inc. Recent Developments
11.8 Covidien plc.
11.8.1 Covidien plc. Company Details
11.8.2 Covidien plc. Business Overview
11.8.3 Covidien plc. Hospital Infection Prevention And Control Introduction
11.8.4 Covidien plc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.8.5 Covidien plc. Recent Developments
11.9 Crosstex International, Inc.
11.9.1 Crosstex International, Inc. Company Details
11.9.2 Crosstex International, Inc. Business Overview
11.9.3 Crosstex International, Inc. Hospital Infection Prevention And Control Introduction
11.9.4 Crosstex International, Inc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.9.5 Crosstex International, Inc. Recent Developments
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Details
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. Hospital Infection Prevention And Control Introduction
11.10.4 Danaher Corp. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.10.5 Danaher Corp. Recent Developments
11.11 Diversey, Inc.
11.11.1 Diversey, Inc. Company Details
11.11.2 Diversey, Inc. Business Overview
11.11.3 Diversey, Inc. Hospital Infection Prevention And Control Introduction
11.11.4 Diversey, Inc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.11.5 Diversey, Inc. Recent Developments
11.12 Getinge Group
11.12.1 Getinge Group Company Details
11.12.2 Getinge Group Business Overview
11.12.3 Getinge Group Hospital Infection Prevention And Control Introduction
11.12.4 Getinge Group Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.12.5 Getinge Group Recent Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Hospital Infection Prevention And Control Introduction
11.13.4 Johnson & Johnson Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.13.5 Johnson & Johnson Recent Developments
11.14 Halyard Health, Inc.
11.14.1 Halyard Health, Inc. Company Details
11.14.2 Halyard Health, Inc. Business Overview
11.14.3 Halyard Health, Inc. Hospital Infection Prevention And Control Introduction
11.14.4 Halyard Health, Inc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.14.5 Halyard Health, Inc. Recent Developments
11.15 Matachana Group
11.15.1 Matachana Group Company Details
11.15.2 Matachana Group Business Overview
11.15.3 Matachana Group Hospital Infection Prevention And Control Introduction
11.15.4 Matachana Group Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.15.5 Matachana Group Recent Developments
11.16 Medivators, Inc.
11.16.1 Medivators, Inc. Company Details
11.16.2 Medivators, Inc. Business Overview
11.16.3 Medivators, Inc. Hospital Infection Prevention And Control Introduction
11.16.4 Medivators, Inc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.16.5 Medivators, Inc. Recent Developments
11.17 Purdue Pharma LP
11.17.1 Purdue Pharma LP Company Details
11.17.2 Purdue Pharma LP Business Overview
11.17.3 Purdue Pharma LP Hospital Infection Prevention And Control Introduction
11.17.4 Purdue Pharma LP Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.17.5 Purdue Pharma LP Recent Developments
11.18 Sealed Air Corp.
11.18.1 Sealed Air Corp. Company Details
11.18.2 Sealed Air Corp. Business Overview
11.18.3 Sealed Air Corp. Hospital Infection Prevention And Control Introduction
11.18.4 Sealed Air Corp. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.18.5 Sealed Air Corp. Recent Developments
11.19 Semperit AG Holding
11.19.1 Semperit AG Holding Company Details
11.19.2 Semperit AG Holding Business Overview
11.19.3 Semperit AG Holding Hospital Infection Prevention And Control Introduction
11.19.4 Semperit AG Holding Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.19.5 Semperit AG Holding Recent Developments
11.20 Synergy Health plc.
11.20.1 Synergy Health plc. Company Details
11.20.2 Synergy Health plc. Business Overview
11.20.3 Synergy Health plc. Hospital Infection Prevention And Control Introduction
11.20.4 Synergy Health plc. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.20.5 Synergy Health plc. Recent Developments
11.21 Terumo Corp.
11.21.1 Terumo Corp. Company Details
11.21.2 Terumo Corp. Business Overview
11.21.3 Terumo Corp. Hospital Infection Prevention And Control Introduction
11.21.4 Terumo Corp. Revenue in Hospital Infection Prevention And Control Business (2019-2024)
11.21.5 Terumo Corp. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
3M Company
Ansell Ltd.
Belimed AG
Bemis Company, Inc.
B. Braun Melsungen AG
Cantel Medical Corp.
Cardinal Health, Inc.
Covidien plc.
Crosstex International, Inc.
Danaher Corp.
Diversey, Inc.
Getinge Group
Johnson & Johnson
Halyard Health, Inc.
Matachana Group
Medivators, Inc.
Purdue Pharma LP
Sealed Air Corp.
Semperit AG Holding
Synergy Health plc.
Terumo Corp.
听
听
*If Applicable.
